The two MHH researchers Lucas John Müntnich and Professor Christian Kratz refer to the cluster analysis of the study, according to which cancer-free survival depends on the classification of the underlying variant. Copyright: Karin Kaiser/MHH. (With permission.)
A new form of cluster analysis enables the development of personalized cancer screening tests. As presented at the 7th International LFS Association Symposium held in Philadelphia in October 2024, Professor Christian Kratz, LFSA Medical & Scientific Advisory Board Member, and his team just published their findings, entitled “Cancer risk in carriers of TP53 germline variants grouped into different functional categories,” in the JNCI Cancer Spectrum (January 2025). See the press release.
